Highlights d High-throughput screen for unbiased detection of lowaffinity pathogen-host interaction 
INTRODUCTION
Plasma membrane-tethered proteins and secreted factors, collectively referred to as extracellular proteins, regulate cell communication by interacting with other macromolecules in the extracellular milieu. Most viruses exploit proteins expressed on the cell surface to invade the host cell, initiate replication, and mediate subsequent viral propagation. Therefore, uncovering the cellular receptors responsible for viral entry is of utmost importance to understanding infection and guiding the development of novel therapeutics and vaccines. Historically, the identification of host cell receptors has represented a major challenge due to the limited compatibility of most technologies with the detection of low-affinity protein-protein interactions (PPIs) which, in many instances, characterize the extracellular interactomes (Martinez-Martin, 2017; Wright et al., 2010) .
Widely utilized methods for the identification of viral receptors, such as affinity-purification coupled to mass spectrometry (AP/MS), are limited to specific cell types and highly expressed receptors. In addition, the requirement of harsh detergents for receptor solubilization may interfere with the detection of relevant PPIs ( Figure S1A ). Consequently, these methods are best suited for detection of the most stable and abundant binding partners and are generally not suitable for detection of transient interactions. To overcome these limitations, we took advantage of the avidity-based extracellular interaction screen (Avexis) method, previously developed by the Wright lab (Bushell et al., 2008) , and further optimized this technology to allow systematic and high-throughput interrogation of receptor-ligand interactions. To this end, we established a library consisting of nearly all human single transmembrane (STM) receptors and set up an automated platform for robust, unbiased, and cell-type-independent detection of both stable and low-affinity extracellular virus-host interactions. This method involves oligomerization of the query protein, resulting in increased avidity that mimics the molecular environment of two opposing membranes (cell surface and viral envelope), thus allowing detection of physiologically relevant pathogen-host receptor interactions.
To validate the applicability of this technology and enable discovery of relevant cell-host interactions, we selected the human cytomegalovirus (HCMV) as a model system. HCMV infects more than 70% of the human population, is responsible for high morbidity and mortality in immunocompromised patients and remains the leading viral cause of congenital birth defects (Plotkin and Boppana, 2018) . HCMV exhibits a broad cellular tropism, comprising epithelial/endothelial cells, fibroblasts, monocytes, macrophages, smooth muscle cells, neurons, stromal cells, and hepatocytes (Campadelli-Fiume et al., 2012; Li and Kamil, 2015) . HCMV utilizes different envelope glycoproteins to engage functionally unrelated entry receptors, providing redundancy for viral entry (Vanarsdall and Johnson, 2012) . While the HCMV homotrimer gB catalyzes membrane fusion between virus and infected cells, two gH/gL-containing complexes regulate viral tropism (Ciferri et al., 2015a; Vanarsdall and Johnson, 2012) . Specifically, gHgLgO (trimer) is primarily required for infection in fibroblasts, whereas gHgLpUL128-131A (pentamer) is required for viral entry in epithelial, endothelial, and myeloid cells (Kabanova et al., 2016; Ryckman et al., 2008) . The pentameric complex represents the main target of neutralization against HCMV, eliciting neutralizing antibodies several orders of magnitude more potent than any other HCMV complex (Ciferri et al., 2015b; Kabanova et al., 2014; Macagno et al., 2010) . Despite considerable efforts in vaccine and therapeutic development, HCMV infection still represents an unmet clinical need and a life-threatening disease in immunocompromised individuals and newborns (Plotkin and Boppana, 2018; Revello and Gerna, 2004) . This discrepancy is largely explained by the limited understanding of basic aspects of HCMV infection, including the cellular receptors mediating HCMV entry, which have remained mostly unknown (Sathiyamoorthy et al., 2017) .
We recently identified PDGFRa as a receptor for the trimer using AP/MS (Kabanova et al., 2016) . Nevertheless, our studies failed to identify any additional HCMV interactors, including the long-elusive receptor(s) for the HCMV pentamer. Here, we establish a cell-independent and high-sensitivity receptor discovery platform and elucidate the HCMV trimer and pentamer complexes' receptome. Our results identify neuropilin 2 (Nrp2) as the functional receptor of the pentamer that mediates infection of epithelial and endothelial cells and further validate PDGFRa as a receptor for the trimer in fibroblasts (Kabanova et al., 2016) . Moreover, we uncover additional human receptors that specifically interact with HCMV trimer or pentamer complexes, suggesting a potential role for these host factors during HCMV infection. Using a combination of electron microscopy and mass spectrometry, we elucidate the architecture of the Nrp2-pentamer complex and use this model as a framework for understanding HCMV antibody-based neutralization and propose a mechanism for HCMV entry.
RESULTS

Multiple Host Cell Receptors Interact with HCMV Trimer and Pentamer Complexes
The STM receptors are essential regulators of many physiological and pathological processes, including cellular communication and signaling, self versus non-self-recognition, and immune response to infection. In the present study, we use bioinformatics tools and manual curation to build a library consisting of nearly all surface-expressed STM human receptors (1,297 unique proteins, Tables S1 and S2), cloned as extracellular domains (ECD) and fused to a C-terminal human IgG1 (Fc) tag to facilitate expression and ease of manipulation ( Figure 1A) . We then established a high-throughput methodology to systematically interrogate this STM receptor library for new extracellular protein interactions and demonstrated the power of this approach to identify known receptor-receptor interactions characterized by a wide range of affinities (nanomolar to micromolar K D ), with robust signal/noise ratio ( Figure S2 ).
We made use of this platform to investigate novel virus-host interactions, using HCMV trimer and pentamer complexes as query proteins (Figures 1B, 1C, S3A, and S3B) . Both trimer and pentamer are inserted at the HCMV envelope through a single transmembrane region at the C terminus of gH (Ciferri et al., 2015a) , exposing the remaining part of the complexes, and in particular, gO and the ULs subunits, to interact with cellular receptors. To enhance binding avidity, we replaced the C-terminal transmembrane region of gH with the cartilage oligomeric matrix protein (COMP) scaffold and enzymatic reporter (Bushell et al., 2008; Wright et al., 2010 ) ( Figure S3C ). We started with the analysis of HCMV trimer extracellular receptome, for which we had previously identified PDGFRa as a functional receptor (Kabanova et al., 2016) . PDGFRa was identified as a top scoring hit, consistent with our previous findings (Kabanova et al., 2016) ( Figure 1B) . Notably, we identified two additional cellular binding partners: the transforming growth factor beta receptor type 3 (TGFbRIII), a membrane proteoglycan serving as a co-receptor for other TGF-beta receptors (Andres et al., 1989) , and neuregulin2 (NRG2), a ligand for ERBB3 and ERBB4 tyrosine kinase receptors, which are involved in the growth and differentiation of epithelial, neuronal, and glial cells (Carraway et al., 1997) (Figures  1B and S3A; Table S1 ).
We next sought to identify the host receptor(s) for HCMV pentamer. This effort identified neuropilin-2 (Nrp2) as the main receptor for the HCMV pentamer ( Figure 1C ; Table S2 ). Nrp2 is a human receptor involved in semaphorin and VEGF binding (Pellet-Many et al., 2008) and has recently been shown to be the host factor responsible for Lujo virus entry (Raaben et al., 2017) . Moreover, our screening identified at least three additional putative receptors including thrombomodulin (THBD), an endothelial-specific type I membrane receptor that binds thrombin (Maruyama et al., 1985) , LILRB3, a member of the leukocyte immunoglobulin-like receptor family, and FCAR, the immunoglobulin alpha Fc receptor ( Figure 1C ; Table S2 ). Importantly, the same receptomes were identified for the trimer and pentamer complexes encoded by both Merlin and VR1814 HCMV strains (Figures S3A and S3B; Tables S1 and S2) .
Next, we used biolayer interferometry (BLI) as an additional biophysical method to confirm the identified interactions using HCMV trimer and pentamer complexes produced as recombinant, purified proteins. These results confirmed high-affinity binding of the HCMV trimer to PDGFRa (Kabanova et al., 2016) (Figures 2A and 2C ) and validated the interaction between trimer and TGFbRIII (K D z2.7 3 10 À7 +/À 0.25 M) (Figures 2A, 2C , and S3D). However, we could not detect binding to NRG2 using BLI or surface plasmon resonance (data not shown), potentially indicating a very low-affinity transient interaction between NRG2 and the trimer that would require enhanced avidity through protein oligomerization. BLI analyses also validated pentamer We generated a protein library consisting of $1,300 unique single transmembrane-containing (STM) receptors. The ECD of each human receptor was fused to a hIgG-Fc tag and transiently transfected into human cells for their generation as soluble products. Conditioned media enriched in individual clones was collected, and the prey receptors captured on protein A-coated plates. Any protein of interest (query) can be oligomerized by fusion to a pentameric helical region of rat COMP (PDB: 1VDF), to allow for enhanced avidity and detection of both stable and transient interactions, as shown in the schematic. The query is assayed directly in conditioned media. Binding of the query protein to specific prey human receptors in the library is detected by colorimetric enzymatic turnover of nitrocefin. Data analysis and hit identification are followed by hit validation using biophysical methods such as biolayer interferometry (BLI) or size exclusion chromatography (SEC). Tables S1 and S2. binding to the two most prominent hits, Nrp2 (K D z3.3 3 10 À8 +/ À 0.35 M) and THBD (K D z2.1 3 10 À8 +/À 0.3 M), as well as a weaker interaction with the receptor LILRB3 ( Figures 2B, 2C , and S3D). No specific binding to FCAR was observed using BLI or surface plasmon resonance (data not shown). Despite being detected as a lower scoring hit, we tested the interaction to CD46, given this receptor had been previously identified to be involved in viral infection (Gaggar et al., 2003; Santoro et al., 1999) , and observed a weak interaction between this receptor and the HCMV pentamer ( Figures 2B, 2C , and S3D). Notably, AP/MS following membrane isolation from ARPE-19 epithelial cells and pentamer clustering using the anti-gH-specific monoclonal antibody (mAb) 3G16 (Macagno et al., 2010) confirmed pentamer binding to Nrp2 (Figures S1B and S1C; Table S3 ) but did not identify the lower affinity binder CD46 or the more stable interacting partner THBD (whose expression is limited to endothelial cells; Figures S1B, S1C, and S4). These results highlight Figure S3D . N.B., no binding detected by BLI.
the proficiency of our high-throughput technology to enable cell-independent receptor discovery with enhanced sensitivity in detecting both low and high-affinity interactions.
Functional Characterization of the HCMV Entry Complex Receptors
We next investigated the relative expression of the newly identified receptors Nrp2, THBD, CD46, TGFbRIII, as well as PDGFRa, in fibroblasts (MRC-9), epithelial (ARPE-19), and endothelial cells (HUVECs) using flow cytometry to measure cell surface expression ( Figure S4 ). CD46, Nrp2, and TGFbRIII receptors were expressed in ARPE-19 epithelial cells, HUVECs, and MRC-9 fibroblasts, whereas expression of PDGFRa and THBD receptors was restricted to MRC-9 fibroblasts and HUVECs, respectively ( Figure S4 ). Immunoblot analysis indicated comparable expression levels for Nrp2 in all cell types investigated (Figure S5A ), in agreement with the similar infection levels observed in ARPE-19 epithelial and HUVECs ( Figure S5C ). As expected, while MRC-9 fibroblasts expressed similar levels of Nrp2, these cells showed increased susceptibility to HCMV infection (Figure S5C ) likely due to expression of PDGFRa, the functional receptor of the HCMV trimer, which is present exclusively in fibroblasts but not in epithelial nor endothelial cells (Figures S4 and S5B) .
To further validate the identified receptor candidates, we tested the ability of soluble proteins and antibodies to inhibit viral entry in epithelial, endothelial, and fibroblastic cells. We observed that recombinant Nrp2 and a pan-NRP antibody (Appleton et al., 2007) inhibited HCMV infection in epithelial and endothelial cells, in a dose-dependent manner, with a halfmaximal inhibition (IC 50 ) of 1.5 mg/mL for recombinant Nrp2 and 2.8 mg/mL and 6.5 mg/mL for the pan-NRP antibody ( Figures  3A, S5D , and S5E). Recombinant THBD reduced infection in endothelial cells to a lower extent ( Figures 3A and S5E ). In contrast, none of the proteins or the anti-Nrp antibody had any effect on VR1814 fibroblast infection ( Figure 3A) , consistent with the finding that antibodies targeting the pentamer subunits UL128, UL130, and UL131A have no protective effect on fibroblast infection (Macagno et al., 2010) , and viral entry in these cells is principally supported by PDGFRa (Kabanova et al., 2016) , as confirmed by the fact that soluble PDGFRa potently inhibits HCMV infection in MRC-9 fibroblasts with a IC 50 of 2.8 mg/mL ( Figures 3A and S5F ). Taken together, these results indicate that Nrp2 is a physiologically relevant receptor for HCMV pentamer-dependent entry in epithelial and endothelial cells, while PDGFRa has a major role in fibroblast infection (Figure 3A) . In addition, these results suggest a potential role for THBD in endothelial cell infection.
Next, in order to determine if the identified receptors promoted viral entry in vivo, we performed lentiviral overexpression in ARPE-19 and MRC-9 cells and confirmed their expression levels by flow cytometry analysis ( Figures 3B, 3C , and S6A). Overexpression of Nrp2 in ARPE-19 resulted in a $2.5-fold increase infection by the clinical isolate HCMV VR1814, while CD46, THBD, and TGFbRIII overexpression had no effect on HCMV entry ( Figure 3B ). In contrast, lentivirus overexpression of these receptors in MRC-9 fibroblasts did not increase HCMV infection, likely because viral entry in this cell line is principally mediated by the trimer and PDGFRa (Kabanova et al., 2016) (Figure 3C ). These results confirmed a role for Nrp2 in mediating pentamerdependent HCMV infection in epithelial and endothelial cells in vivo and corroborated the importance of the PDGFRa receptor for fibroblast infection.
To further validate these findings, we used CRISPR-Cas9-mediated gene disruption technology (Sanjana et al., 2014) to knock out these receptors in the haploid myeloid cell line (HAP-1), which can be infected by the HCMV clinical strain VR1814 (Kabanova et al., 2016) (Figure 4 ; Table S4 ). Knockout of individual cell surface receptors was confirmed by flow cytometry analysis ( Figure S6B ). While deletion of TGFbRIII or CD46 had no effect on VR1814 infection, Nrp2 gene knockout significantly reduced infection (<10%) of HAP-1 ( Figure 4A and 4B). Moreover, overexpression of Nrp2 in HAP-1 cells where Nrp2 had been previously knocked out and rescued and significantly increased VR1814 infection ( Figures 4A, 4B , and S6D), similarly to Nrp2 lentiviral overexpression in ARPE-19 ( Figure 3B ). Next, we further characterized the effect of receptor knockdown in HUVEC, confirming that Nrp2 downregulation almost completely abolished infection by VR1814 (<5% of infected cells), whereas CD46, TGFbRIII, and THBD downregulation had no effect (Figures 4C, 4D, and S6C) . In addition, Nrp2 depletion in ARPE-19 epithelial cells by small interfering RNA (siRNA) led to a strong reduction of HCMV infection (Figures 4E and S6E) . In contrast, Nrp2 knockdown had only a limited effect on MRC-9 infection by the HCMV clinical isolate (that express both trimer and pentamer complexes), consistent with the ability of VR1814 HCMV to infect fibroblasts in a trimer-dependent manner (Figures 4F and S6E) . Similarly, knockdown of PDGFRa in these cells resulted in partial inhibition of VR1814 infection (Figures 4F and S6F), as previously described (Kabanova et al., 2016) , indicating that both Nrp2 and PDGFRa receptors can mediate fibroblast infection, with PDGFRa playing a more prominent role. Consistently with this hypothesis, the mixture of Nrp2 and PDGFRa more potently decreased infection of MRC-9 cells, as compared to PDGFRa alone ( Figure 4G ).
Altogether, our data confirm that PDGFRa is the receptor that mediates trimer-dependent entry in fibroblasts and demonstrates that Nrp2 is the functional receptor for the HCMV pentamer for infection of epithelial and endothelial cells. These results also indicate that the higher susceptibility of fibroblasts to HCMV infection results from the expression of both Nrp2 and PDGFRa receptors. Furthermore, we identify additional cell surface proteins as binding partners for the trimer and the (B) and MRC-9 (C) using lentiviral vectors and then infected with the VR1814 virus. Overexpression of Nrp2 increased VR1814 viral infection in ARPE-19 epithelial, whereas no effect was observed in MRC-9 fibroblasts. Shown is the mean ± SEM of four independent experiments. Statistical significance was evaluated by t test (Mann-Whitney test). ****p < 0.0001. See also Figure S4 . (legend continued on next page) pentamer. While CD46, THBD, and TGFbRIII receptors interact with pentamer or trimer in vitro, they do not seem to be essential for viral entry. However, it is possible that these receptors might be relevant in vivo, perhaps by mediating immunoregulatory functions that may facilitate HCMV infection or by functioning as co-receptors. The relevance of these factors in mediating HCMV entry will be the subject of future studies.
Architecture of Pentamer-Nrp2 Complex
The identification of Nrp2 as the key functional HCMV receptor in epithelial/endothelial cells led us to recombinantly reconstitute the HCMV pentamer-Nrp2 complex and to determine its architecture using negative staining electron microscopy (EM) and single-particle analysis ( Figure S7A ). To facilitate the EM studies (Ciferri et al., 2015b) , we analyzed the pentamer-Nrp2 complex bound to the fragment antigen-binding (Fab) region of the neutralizing antibody 3G16. This complex adopted a strong preferential orientation, which precluded high-resolution structure determination and required the use of the random conical tilt (RCT) reconstruction method to determine its structural organization (Figures 5A and S7A) . We determined the 3D reconstruction of the pentamer-Nrp2-3G16 complex and used rigid body fitting to accommodate the X-ray structure of HCMV pentamer (Chandramouli et al., 2017 ) and a Fab model of 3G16 into the RCT density map ( Figure 5A ). When arranged into the RCT reconstruction, these models accounted for a large part of the electron density and were almost entirely enclosed by it. Remaining imperfections in the fit are likely due to flattening artifacts intrinsic to negative-stain EM experiments and to the pentamer's reported flexibility (Chandramouli et al., 2017) . Extra densities emerging from the ULs subunits indicated the position occupied by the Nrp2 domains ( Figure 5A ).
To identify potential regions of interaction between pentamer and Nrp2 and orient the Nrp2 domains within the EM density map, we carried out chemical cross-linking coupled to MS analysis (Ciferri et al., 2015b; Leitner et al., 2016) on the same sample used for EM analyses (Figures 5B and S7B; Table S5 ). We made use of three distinct cross-linkers: disuccinimidyl suberate (DSS), a homo-bifunctional cross-link reacting with the primary amines of lysines, pimelic dihydrazide (PDH), a homo-bifunctional reagent that cross-links acidic residues, and 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM), a zero-length cross-linker connecting Lys with Asp or Glu residues. This analysis identified several intramolecular and intermolecular interactions within the pentamer-Nrp2 complex (Figures 5B and S7B; Table S5 ).
The extracellular region of Nrp2 contains two N-terminal CUB domains (a1 and a2), followed by two middle coagulation factor V/VIII homology domains (b1 and b2) and one C-terminal MAM domain, which is separated from the a1-a2-b1-b2 domains by a long flexible linker (Appleton et al., 2007) . Prior structural studies of the Nrp2 domains have demonstrated that the a1 domain binds to the core region formed by the a2-b1-b2 domains with moderate affinity and suggest that the a1 domain could undergo large conformational changes with respect to the remainder of Nrp2 either in solution or upon ligand binding (Appleton et al., 2007) .
Our cross-linking analysis indicates that individual domains of Nrp2 interact with distinct regions of the pentamer. We observed binding between the a1 domain of Nrp2-(K 84 , D 92 , D 94 , E 96 , and D 99 ) and gL-D 146 , UL130-(E 95 , K 108 , and K 109 ), and UL128-K 154 ( Figure 5B ; Table S5 ). These data led us to place the a1 domain of Nrp2 in the RCT density map near the elbow formed by the V-shaped UL components of the pentamer (Figures 5A and 5C, inset 1). Conversely, the a2-b1-b2 domains of Nrp2-(K 233, K 326, E 370 ) cross-linked with UL128-(K 47 , E 62, K 92 ) and UL131A-K 27 on the opposite surface of the pentamer, indicating that the Nrp2 a2-b1-b2 domains likely occupy the larger density emerging from the ULs region of the pentamer (Figures 5A and 5C, inset 2). Taken together, these data suggest that the a1 domain rearranges itself with respect to the remainder of Nrp2 upon pentamer binding, as previously hypothesized (Appleton et al., 2007) . Cross-linking data were inconclusive with regard to the position of the MAM domain of Nrp2 relative to the pentamer complex ( Figure S7B ). In fact, several cross-links were detected between the MAM domain and a large area of the Nrp2-pentamer complex, consistent with the presence of the long unstructured region between the b2 and MAM domains (Figures 5B and S7B; Table S5 ).
Biochemical Characterization of Pentamer-Nrp2 Interaction
To identify the Nrp2 domains required for HCMV pentamer binding, we purified Nrp2 deletion mutants lacking a1, b1b2, or MAM domains and used size exclusion chromatography (SEC) analysis to investigate their association to HCMV pentamer, using Nrp2 ectodomain (Nrp2-Ecto) as a control ( Figure 5D ). Nrp2-a1a2 and Nrp2-a2b1b2 were largely unable to bind HCMV pentamer. In both cases, Nrp2 and pentamer eluted separately with almost unaltered elution volumes relative to those of the isolated components ( Figure 5D ). On the other hand, Nrp2-a1a2b1b2 (Nrp2-DMAM) interacted with the pentamer and comigrated in a higher molecular weight fraction, indicating that the MAM domain might be dispensable for this interaction.
Prior mutagenesis studies conducted by Schuessler et al. (2008 Schuessler et al. ( , 2010 Schuessler et al. ( , 2012 identified patches of surface-exposed charged residues on pUL128-UL131A, that, if mutated and reconstituted into the virus, caused a strong reduction of tropism in endothelial cells. These data suggested that these regions on the surface of the pentamer could be important in mediating either pentameric complex assembly or receptor interaction. We used this information in conjunction with our cross-linking analysis to engineer a set of 28 HCMV pentamer complexes, each carrying mutations in one of the Uls subunits and test their (Chandramouli et al., 2017) and a model of 3G16 Fab were placed into the RCT reconstruction of the pentamer/Nrp2/ 3G16-Fab complex. Additional densities, emerging from the UL subunits, indicate the localization of Nrp2.
(legend continued on next page) ability to bind Nrp2, fused to a fragment crystallizable region (Nrp2-Fc) ( Figure 5F ; Table S6 ). Western blot analysis indicated that the majority of these mutants were expressed. Mutations of the pUL128 subunit at the residues K 47 and K 92 (Mut. 5-9), identified by our cross-linking studies, as well as the charged peptides EIR 72-74 (Mut. 10) and EADGR [104] [105] [106] [107] [108] 12) , dramatically reduced Nrp2 interaction ( Figure 5E ), while mutation in the DGE 60-62 and EK 68-69 peptides (Mut. 1, 2) did not affect Nrp2 binding. Interestingly, mutations in the charged peptide KKHKR 154-158 (Mut. 3, 4), identified by cross-linking analysis and previously reported to be important for HCMV entry (Schuessler et al., 2008) , did not affect Nrp2 binding. Consistent with previous mutagenesis studies (Schuessler et al., 2010) , mutations of pUL130 comprising the residues RE 94-95 and KK 108-109 (Mut. 13-16) had no effect on Nrp2 binding, while peptides localized at the C-term region of pUL130 , with the exception of the peptide KQTK 154-157 (Mut. 18), were either poorly expressed or impaired Nrp2 interaction. In agreement with the cross-linking analysis and published mutagenesis studies (Schuessler et al., 2012) , mutations at the N term region of the pUL131A subunit (Mut. 22-25) were particularly important for Nrp2 binding. In this region, pUL131A folds into an extended loop that contacts several regions of Nrp2 ( Figure 5E ). In addition, mutation in the pUL131A peptide RRQNRR 93-98 (Mut. 26) largely affected Nrp2 binding while mutation at the C term region of UL131A, identified by our cross-linking analysis to be important for the MAM domain binding (KR 103-104 : Mut. 27), did not affect Nrp2 interaction that is consistent with our SEC studies ( Figure 5E ). Taken together, our cross-linking, SEC, and mutagenesis data are consistent with the proposed architecture of the pentamer-Nrp2 complex.
HCMV Neutralizing Antibodies Block Nrp2 Binding
Previous studies have established that the UL subunits of the pentamer are the main target of neutralization against HCMV and contain at least seven neutralizing epitopes (Macagno et al., 2010) , five of which are non-overlapping (Ciferri et al., 2015b) . These seven epitopes are divided across two distinct surfaces for neutralization (Ciferri et al., 2015b) on opposite sides of the elbow formed by the V-shaped ULs component of the pentamer (Ciferri et al., 2015b) . One surface includes sites 1, 4, and 6, whereas the second surface includes sites 2, 3, 5, and 7 ( Figure 6 ). We asked whether pentamer-specific neutralizing antibodies block HCMV infection by preventing Nrp2 binding at the cell surface. To answer this question, we compared our pentamer-Nrp2 reconstruction to the available crystal structures of pentamer bound to sites 5 and 7 neutralizing Fabs (Chandramouli et al., 2017) , as well as EM reconstructions of pentamer bound to Fabs for the remaining neutralizing sites (Ciferri et al., 2015b) (Figure 6A ). Fitting these structures into our density map suggested that, with the exception of site 3/7, all the other site-specific antibodies would recognize pULs regions involved in Nrp2 association and therefore would compete for Nrp2 receptor binding ( Figure 6B ). To confirm this hypothesis, we tested if recombinant mAbs generated for each of the ULs neutralizing sites could associate with purified pentamer upon binding of Nrp2. Neutralizing mAbs raised against the C-terminal region of gH (3G16 and MSL109), a component of the pentamer not involved in Nrp2 binding, were used as negative control ( Figure 6C ). Consistent with our structural data, our binding studies indicated that the majority of the neutralizing antibodies, with the exception of site 3/7, compete for binding to Nrp2, indicating that HCMV neutralization mainly occurs by blocking its binding to the Nrp2 receptor ( Figure 7 ).
DISCUSSION
Cellular receptors expressed on the plasma membrane are key determinants of viral tropism and pathogenesis via direct interaction with viral proteins. Notwithstanding their relevance for the design of vaccines and anti-viral therapies, the host factors responsible for viral entry remain, in many cases, unknown. This deficiency is fundamentally associated with the lack of sensitive technologies for detection of interactions between viral and host proteins in the extracellular environment. Here, we establish a library consisting of most STM human receptors and further implement the Avexis technology (Bushell et al., 2008; Wright et al., 2010) for small-scale and high-throughput screening to enable interrogation of the receptor library. Using this approach, we built a unique methodology for unbiased, cell-independent, and automated detection of virus-host receptor interactions characterized by a wide range of affinities, a method that is readily applicable to any virus under investigation. We used this platform to elucidate the extracellular receptome for HCMV trimer and pentamer complexes, demonstrating for the first time, to our knowledge, the power of this technology to deorphanize protein complexes. (B) Chemical cross-linking coupled to mass spectrometry was used to determine the interactions between HCMV pentamer and Nrp2. Several cross-linkers were observed between the Nrp2 a1 domain and residues of pUL130, pUL128, and gL, suggesting that the Nrp2 a1 domain occupies the small density observed in the elbow formed by gL, pUL128, and pUL130. Additional cross-links were observed between the a2 and b1 domains and residues of pUL131 and pUL128 facing outward, indicating that a1-b1-b2 domains of Nrp2 are localized in the large density emerging from the pULs components. Several cross-linkers were observed between the Nrp2 MAM domain and a large surface occupied by the pULs and the b1-b2 domains of Nrp2, indicating an extended flexibility of this domain ( Figure S7B ). (C) Details of the interactions between HCMV pentamer with the a1 and a2-b1-b2 domains of Nrp2 are presented in inset 1 and inset 2, respectively. Residues involved in cross-links with the a1 domain are presented in purple, while those involved in cross-links with the a2-b1-b2 domains are shown in red. (Table S6) , were generated based on our cross-linking analysis and published data (Chandramouli et al., 2017; Schuessler et al., 2008 Schuessler et al., , 2010 Schuessler et al., , 2012 . Each mutant was co-expressed with Nrp2 ECD fused to a fragment crystallizable region (Nrp2-Fc) and tested for binding to Nrp2-Fc immobilized on beads. Expression levels of each of these mutants were tested to assess their ability to assemble into stable pentamer complexes. See also Table S5 .
Here, we discover Nrp2 as the cellular receptor responsible for HCMV pentamer-dependent infection of epithelial and endothelial cells and confirm PDGFRa as the receptor that mediates HCMV entry in fibroblasts. Furthermore, we identify and validate additional HCMV trimer and pentamer binding partners, such as the cell surface molecules CD46, THBD, TGFbRIII, or LILRB3. (A) Representation of unbound HCMV pentamer as compared to HCMV pentamer bound to different neutralizing sites (sites 1-7). X-ray and EM structures of HCMV pentamer bound to neutralizing Fabs (Chandramouli et al., 2017; Ciferri et al., 2015b) were fitted into the obtained RCT density to determine if any of the reported neutralizing antibodies could sterically block pentamer-Nrp2 interaction. With the exception of those targeting site 3/7, the neutralizing antibodies sterically precluded Nrp2 binding. (B) Summary of the interactions described in (A). (C) In vitro binding of Nrp2-pentamer to neutralizing mAbs confirmed that all neutralizing antibodies, with the exception of those targeting site 3/7, block Nrp2 binding. mAbs specific for the C-terminal region of gH (3G16 and MSL109) were used as controls.
Although our data suggest that CD46, THDB, and TGFbRIII do not play a significant role in viral entry, it is plausible that these host factors take part in a yet unrecognized function during infection in vivo, such as immunoregulation or co-receptor binding. In addition to acting as a receptor for several human viruses and bacteria, CD46 induces T cell differentiation and production of interleukin (IL)-10, a feature that may be exploited by pathogens as an immunosuppression strategy (Astier, 2008) . LILRB3, in turn, has been shown to downregulate B cell activation through recruitment of phosphatases via phosphorylation of immunoreceptor tyrosine-based inhibitory (ITIM) motifs (Huang et al., 2010) . Interestingly, increasing evidence indicates that viruses preferentially interact with ITIM-containing receptors (MartinezMartin et al., 2016; Ong et al., 2016) , including the highly related molecule LILRB1, which is targeted by multiple human viruses including HCMV (Chan et al., 2014) . In addition, THBD, a major regulator of inflammation and coagulation, has been shown to be significantly upregulated in Lassa virus-infected patients (Zapata et al., 2013) , suggesting its involvement in vascular abnormalities that have also been frequently associated with HCMV infection (Caposio et al., 2011) . Further studies will be needed to elucidate the role of these host factors during HCMV infection. While our methodology enables robust identification of interactions with STM receptors, it is not suited in its current form for interrogation of multitransmembrane-containing receptor interactions. Based on partial sequence homology with chemokines, it has been hypothesized that the pUL128-131A proteins act as chemoattractants (Sun et al., 2009; Vomaske et al., 2012) , therefore, we cannot exclude that the HCMV complexes interact with additional receptors, such as G protein-coupled receptors, a topic that may be addressed in future studies. Nonetheless, the present study unequivocally demonstrates that Nrp2 and PDGFRa receptors are essential for viral entry, suggesting that additional interactions with other receptors (if any) may not play a pivotal role in this process.
The use of two distinct receptors is a common mechanism adopted by herpes viruses to enter host cells (Adler et al., 2017) , and our findings indicate that HCMV tropism relies on at least two distinct receptors: PDGFRa, which mediates HCMV entry in fibroblasts upon binding to the trimer (Kabanova et al., 2016; Wu et al., 2017) , and Nrp2, which interacts with the pentamer in epithelial and endothelial cells. Cross-linking and structural data indicate a dynamic repositioning of the Nrp2 receptor upon pentamer binding, suggesting a mechanism of ligandinduced conformational change during cell entry ( Figures 5A  and 5B ). In addition, the architecture of the pentamer-Nrp2 complex indicates that HCMV neutralizing antibodies, with the exception of those targeting site 3/7, block HCMV entry in epithelial and endothelial cells by interfering with Nrp2 receptor binding ( Figure 6 ). Previous studies indicated that HCMV gH/gL interacts with gB and that this interaction is important for HCMV membrane fusion to host cells (Fouts et al., 2014) . We speculate that site 3/7 antibodies could neutralize HCMV entry by preventing conformational changes required for interaction with gB or activation of membrane fusion (Figure 7) .
Several studies suggested that HCMV uses the epidermal growth factor receptor (EGFR) and different combinations of a and b integrins to infect host cells (Feire et al., 2004; Wang et al., 2003) . However, EGFR role as a direct HCMV receptor was later challenged (Isaacson et al., 2007; Vanarsdall et al., 2012) . Moreover, while we reported that EGFR and other members of the ErbB family are activated upon infection by HCMV Model for HCMV entry in human cells using the trimer and pentamer complexes. HCMV trimer interacts with PDGFRa via its gO subunit and induces the activation of gB homotrimer at the plasma membrane (Kabanova et al., 2016) . The pentamer binds Nrp2 (this manuscript), promoting endocytosis of the viral particles. The release of the viral particles from the endosomal compartment could be mediated by acidification of the vesicles.
clinical strain, we could not detect a direct binding between the pentamer and any member of the ErbB receptors (Kabanova et al., 2016) . It was recently shown that neuropilins play a central role for the crosstalk between EGFR, VEGFR, and integrin family members in tumor cells (Diaz-Vera et al., 2017; Peacock et al., 2018) . It is tempting to speculate that EGFR activation is a consequence of the neuropilin pathway activation upon direct engagement by the viral pentamer. EGFR activation could then play an additional role in the amplification of HCMV entry or trigger signaling transduction in the infected host cells, promoting viral dissemination and persistence (Collins-McMillen et al., 2017) .
HCMV entry in epithelial and endothelial cells is vital for virus proliferation, disease progression, and persistence and occurs by endocytosis followed by low-pH-dependent fusion. It was recently shown that Nrp2 is actively involved in the endocytic pathway by mediating the internalization of different classes of molecules (Diaz-Vera et al., 2017) . We therefore hypothesize that HCMV has evolved a strategy for cellular entry, using the pentamer to target Nrp2 and hijack the cell's endocytic machinery ( Figure 7) . The pentamer/Nrp2 interaction may have additional clinical implications since several reports have independently associated Nrp2 dysregulation and HCMV infection with neuronal degeneration, tumor progression, and angiogenesis (Luganini et al., 2016) . Additional studies are required in order to address these hypotheses.
In summary, we have established an extensive library of human receptors and developed a cell-type-independent, highsensitivity, and automated receptor discovery platform to determine novel pathogen cell host receptomes. This technology is applicable to the study of individual subunits or large multi-protein complexes and provides a new avenue to inform basic research and drug discovery. Here, we illustrate the value of this approach to uncover the long-elusive cellular receptor for HCMV pentamer and provide the basis for understanding the mechanism of HCMV entry and neutralization. These studies pave the way for the development of novel vaccines and therapies against HCMV infection.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Cells and viruses
The Expi293F is a female human embryonic kidney cell line transformed and adapted to grow in suspension (ThermoFisher). The Expi293F cells were grown in Expi293 expression media, cultured at 37 C, 5% CO 2 and 150 rpm. ARPE-19 is a male cell line derived from the spontaneously arising retinal pigment epithelia (RPE) cell line (ATCC CRL-2302) and was cultured in D-MEM/F-12 + GlutaMAX (Thermo Fisher Scientific) supplemented with 10% FBS and penicillin/streptomycin (Thermo Fisher Scientific). MRC-9 is a female human embryonic lung fibroblast cell line (ATCC CCL-212) and was cultured in Minimum Essential Medium Eagle (Sigma-Aldrich) supplemented with 10% FBS, glutamine and penicillin/streptomycin. HAP-1 cell is a male chronic myelogenous leukemia (CML) cell line derived from KBM-7 cell line, obtained from Horizon Genomics GmbH and cultured in Iscove's Modified Dulbecco's Medium (IMDM) + GlutaMAX in the presence of 10% FBS and penicillin/streptomycin. Human Umbilical Vein Endothelial Cells (HUVEC, pool from males and females donors) obtained from Lonza and kindly provided by Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, and were cultured in EndoGRO TM -VEGF Complete Media (Millipore). HEK293FT, is a female human embryonic kidney cell line isolate derived from human embryonal kidney cells transformed with the SV40 large T antigen (Thermo Fisher Scientific). The HEK293FT cell line was cultured in D-MEM+10% FBS, 0.1 mM MEM Non-Essential Amino Acids, GlutaMAX, 1 mM MEM Sodium Pyruvate and 500 mg/mL Geneticin (Thermo Fisher Scientific). All cell lines were confirmed to be free of Mycoplasma. HCMV clinical isolate VR1814 was kindly provided by Virologia e Microbiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. HCMV VR1814 was propagated in HUVECs. ARPE-19, HAP-1, HUVEC and MRC-9 cells are not listed according to ICLAC 3/10/ 2014. ARPE-19, MRC-9 and HAP-1 cells were authenticated by analysis of Short tandem repeat (STR) loci at ATCC and Horizon Genomics GmbH respectively. HUVEC were authenticated by expression of CD31/105, von Willebrand Factor VIII, and are positive for acetylated low-density lipoprotein uptake. HEK293FT were purchased from Thermo Fisher Scientific and authenticated by their ability to produce high titer infective lentiviral particles.
METHOD DETAILS
Generation of HCMV glycoprotein and Fab constructs
Codon-optimized (for expression in human cells) HCMV VR1814 and Merlin gH, gL, UL128, UL130, UL131A and Nrp2 genes, were synthesized and subcloned into the plasmid expression vector pRK5 (Genentech). The gH gene comprised only the extracellular region (first 715 [VR1814] or 716 [Merlin] amino acids). Plasmids encoding 3G16 Fab fragments were derived from DNAs encoding the heavy and light chains of the antibodies and were subcloned into the expression vector pRK5. For protein purification purposes, UL130 and Fab VH chains were fused to a C-terminal double Strep Tag. For the Cell-Surface Receptor Interaction screen, gH (1-715/1-716) was fused to the pentameric helical region of rat cartilage oligomeric matrix protein (COMP) in tandem with the sequence of b-lactamase: For mutagenesis studies, gBlocks (IDT Technologies) encoding individual ULs mutants were ordered with flanking restriction enzyme sequences BamHI/EcoRI. These sites were used to clone these constructs in the plasmid expression vector pRK5. gBlocks sequences are reported in Table S6 . All constructs were sequence verified.
Recombinant proteins and chemicals
Recombinant extracellular domains of human CD46, NRG2, Nrp2, THBD, TGFbRIII and PDGFRa fused to affinity purification tags were produced in mammalian cells and purified in house using affinity chromatography followed by elution and size exclusion chromatography (SEC). LILRB3, FCAR, Nell1, TGFb1 and Nrp1 recombinant proteins were obtained from R&D systems. Recombinant Nrp2 purchased from R&D was also tested by surface plasmon resonance (SPR) and Biolayer Interferometry (BLI) experiments for binding to HCMV complexes. Analytical SEC was performed on an Ettan LC FPLC System (Amersham Biosciences) using a Superdex 200 PC 3.2/30 column (Amersham Biosciences).
Protein Purification
Expi293F cells were transfected with plasmids encoding individual subunits. Cultures were maintained for 7 days at 37 C. Pentamer and Fabs were purified from mammalian cell supernatants by affinity chromatography on Strep-Tactin superflow high capacity resin (IBA GmbH, Gö ttingen, Germany) using the C-terminal double Strep Tag on the pUL130 subunit and VH chains, as previously described (Ciferri et al., 2015a (Ciferri et al., , 2015b . Proteins were eluted from the resin by competition with elution buffer (25 mM HEPES, pH 7.5, 300 mM NaCl) containing 5 mM desthiobiotin. HCMV complexes and Fabs were then subjected to SEC on a Superose 6 PC 3.2/30 equilibrated in 25 mM HEPES (pH 7.5) and 300 mM NaCl. Complexes between Pentamer, Fabs and Nrp2 were generated by incubation for 2 hr on ice with 1.5 molar excess of Fab and purified by SEC to remove excess Fab.
Human receptor library generation and preparation of conditioned media for Cell-Surface Receptor Interaction Screens The list of single transmembrane (STM) receptors was built upon careful bioinformatics analysis using various algorithms for prediction of protein features, such as protein domains or subcellular locations, including the TMHMM and SignalP Servers (University of Denmark), and Phobius (Centre Stockholm Bioinformatics), followed by manual curation, review of published annotations as well as by careful review of Uniprot annotation for subcellular location. The boundaries of the mature extracellular domains (ECDs) were determined by predicting signal peptides and transmembrane helices or glycosylphosphatidylinositol (GPI)-linkage sites. The ECD of each receptor was synthesized and cloned into a pRK5 vector (Genentech) containing a C-terminal hIgG (Fc) tag. Clones were synthesized according to protein sequences annotated in Uniprot. This effort has generated a library consisting of 1,297 unique STM receptors, alongside selected receptor isoforms, and a number of clones present in duplicates for internal control purposes. The composition of the clone library alongside the boundaries utilized for cloning have been listed in Tables S1 and S2. To prepare the conditioned media for the high throughput screens, the receptor protein library was produced in a high-level human expression system to ensure addition of relevant post-translational modifications such as glycosylation or disulfide bond formation. Briefly, conditioned media were produced by transient transfection into Expi293F cells (Thermo-Fisher, Waltham MA), cultured in Expi293 Expression Medium (Cell Technologies) that was used as seed train and production growth medium. Cells were grown in flasks at 37 C, 5% CO 2 , and 150 rpm agitation speed in a humidified incubator. Cell culture and transient transfections were performed following a fully automated procedure consisting of a TECAN liquid handling system and an integrated MultiDrop combi reagent dispenser. The cells were transiently transfected with individual clones from the STM receptor library using Biomek FX liquid handling robot for automation and higher efficiency, and processed in batches of 96 transfections. Transfections were performed using 25KDa liner PEI. Cell cultures were grown for 7 days before removing the cells by centrifugation at 3,000 g for 20 min.
Protein A-coated plates (384-well format, Thermo Scientific) were used to capture the prey library from conditioned media, by overnight incubation with the cell culture supernatants (enriched in individual ECD-Fc STM receptors) followed by storage at 4 C until use. The same procedure was utilized to generate the oligomeric HCMV pentamer and trimer complexes used as query proteins, which were assayed directly in the conditioned media without any capturing step. Oligomeric HCMV complexes were prepared as 30 mL transient transfections using the cell line and experimental procedure described above. HCMV pentamer and trimer expression in the conditioned media was assessed by measuring b-lactamase activity. A dilution series of the supernatant was added to nitrocefin (0.125 mg/ml) and immediately transferred to a plate reader to record absorbance at 485 nm every minute for a total of 20 min. HCMV complexes conditioned medium for the Cell-Surface Receptor Screen was diluted in PBS to reach a threshold activity of $2 nmol min -1 turnover of nitrocefin, similarly to previously described procedures (Bushell et al., 2008) .
Analysis of ECD-Fc receptor (prey library) expression in conditioned media.
The concentration of each prey receptor ECD-Fc in the conditioned media from transfected cells was estimated using a human IgG Fcƴ TR-FRET assay, similarly to previously described methods (Saraheimo et al., 2013) . AffiniPur F(ab') 2 Goat anti-Human IgG, Fcƴ (Jackson ImmunoResearch) conjugated with Europium Cryptate (Cisbio Bioassays) was used as a donor, whereas an AlexaFluor647â-AffiniPur F(ab') 2 Donkey anti-Human IgG, Fcƴ (Jackson ImmunoResearch) was used as acceptor. Standards, controls and samples were diluted in assay diluent (PBS/0.5% BSA/ 0.05%Tween-20/ 15ppm Proclin), and assayed in 1536-well MaKO plates (Aurora Biotechnologies). A combined donor and acceptor reagent solution was added to each well. Plates were allowed to incubate at room temperature for 1 hr, following ready using a PHERAstar FS (BMG Labtech) plate reader with an excitation wavelength at 320 nm and emission wavelengths at 665 nm and 620 nm. The TR-FRET signal was reported as the ratio of the two emission wavelengths (665 nm/620 nm) multiplied by 10,000. Sample quantification was obtained by interpolating the results from a standard curve. Data were processed with a customized software.
HCMV Pentamer oligomerization and Cell-Surface Receptor Interaction Screen
The oligomerization of the HCMV pentamer or trimer complexes (used as query proteins) was achieved through fusion to the pentameric helical region of rat cartilage oligomeric matrix protein (COMP) as described earlier, allowing for significant avidity enhancement that is key for detection of low affinity binding partners (Wright et al., 2010) . The protein was also fused to b-lactamase to allow for rapid and robust detection of captured query-prey interactions using a colorimetric readout upon addition of the substrate nitrocefin, as previously described (Bushell et al., 2008 ). Preparation of library-coated plates and screening of the oligomeric HCMV entry complexes against the human receptor library was performed using an integrated robotic system consisting of automated liquid handling devices (plate dispensers and washers), to allow for high throughput analysis of protein-protein interactions while minimizing manual operations to improve screening data quality. The Cell-Surface Receptor Interaction Screen was performed utilizing the Avidity-based extracellular interaction screening (Avexis) method (Bushell et al., 2008) , which was further implemented to allow for miniaturized, high throughput screening of a newly built human receptor library (Genentech) consisting of 1,297 unique STM human receptors. The day of the assay, library-coated plates were washed three times with PBS containing Ca 2+ and Mg
2+
. Subsequently, plates were incubated with the conditioned media containing the oligomerized HCMV pentamer or trimer (50 ml/well) and incubated at room temperature for 1 hr. Plates were then washed with PBS-Ca-Mg to remove any free HCMV protein before addition of nitrocefin (Calbiochem) (50 ml/well). Nitrocefin turnover is observed in the presence of b-lactamase activity, indicative of HCMV pentamer or trimer binding to the individual receptor captured in the well. Plates were incubated at room temperature for 1 hr, and HCMV complex-host receptor interactions were identified by measuring absorbance at 485 nm. To normalize the absorbance data, we estimated the maximal absorbance potential of the pentamer and gHgLgO trimer and background signal in each screening plate. Corrected values were represented as a percentage of the maximal signal.
Protein-protein interaction and Fabs competition studies
Interactions between the HCMV protein complexes and the host receptors identified were validated by SPR, using the Proteon XPR36 (Bio-Rad) instrument, or BLI, using an Octet Red System (Pall ForteBio). Briefly, for SPR measurements, the indicated proteins (purified, recombinant receptor extracellular domains) were immobilized on GLC sensor chips using the amino-coupling method. The pentamer was run as analyte at the molar concentrations indicated in each case in PBS containing 0.01% Tween-20. Biolayer Interferometry was used for calculation of kinetic parameters. HCMV interactors were immobilized onto protein A sensors (Pall ForteBio), and binding to soluble pentamer or trimer recombinant complexes was measured using the Octet System. In the case of TGFbRIII interaction, the recombinant receptor ECD was biotinylated using an EZ-link Sulfo-NHS-biotin reagent (ThermoFisher), and captured onto a Streptavidin-coated sensor (Pall ForteBio), prior to testing binding to soluble HCMV trimer. Kinetic data were fit to a Langmuir model using the BiaEvaluation software 4.1
For the competition with the anti-pentamer Fabs, the pentamer was incubated with the relevant Fabs at 100 mg/ml for 30 min at RT, before binding to Nrp2 immobilized on a GLC sensor chip was measured using SPR (Proteon XPR36 instrument). Response units were recorded at the end of the injection and represented as the percentage of binding in the absence of Fabs.
Plasma membrane purification and immunoprecipitation ARPE-19 cells were grown in tissue culture flasks (Nunc, Thermo Fisher Scientific) to confluency. Cells were washed twice with icecold PBS and treated with a plasma membrane protein extraction kit (Abcam). Isolated plasma membranes were incubated with 20 mg of pentamer. Preparation was left for 2 hr with continuous shaking at 4 C and split in two, one half was incubated with protein A beads pre-complexed with 10 mg of 3G16 antibody, and the other half incubated with protein A beads that had been pre-complexed with 10 mg of irrelevant IgG (MPE8, anti-F RSV mAb). Both preparations were further incubated for 60 min with continuous shaking at 4 C. Beads were subsequently washed three times with PBS-NP-40 (0.05%), eluted with glycine (0.2M, pH2.9) and immediately acetone precipitated for mass spectrometry analysis.
Mass spectrometry analysis
Acetone precipitates were dried and re-suspended in water. Samples underwent typical procedures of protein reduction and alkylation and subsequent overnight trypsin digestion according to a protocol elaborated at the Central Proteomics Facility at Dunn School of Pathology, Oxford (de Wet et al., 2011) . Mass spectrometry data were acquired on Q Exactive mass spectrometer via a Nano electrospray source (Thermo Fisher Scientific) coupled to a U3000 nanoHPLC system (Dionex). MaxQuant (version 1.5) and Persus (version V1.5.6 ) software were used to analyze mass spectrometry raw data files.
Flow cytometry staining For cell-surface staining, adherent cells were gently detached with a cell scraper and washed twice with PBS+2% FBS, incubated in PBS + 0.5% BSA + 2 mM EDTA with specific anti-Neuropilin-2 and anti-CD46 antibodies (AF2215 and AF2005, R&D systems), anti-Thrombomodulin antibody (clone 141C01, Abcam), anti-TGFbRIII antibody (T1940, Sigma) or, as isotype control, normal sheep IgG affinity pure (R&D systems), goat a-CMV pp71 (vC-20; Santa Cruz Biotechnology) and mouse IgG1 a-CMV pp72 (clone 6E1; Santa Cruz Biotechnology) at 2 mg/ml for 30 min on ice. After two washes, cells were incubated with rabbit anti-goat IgG (H+L) Alexa Fluor 594 conjugated or donkey anti-sheep IgG (H+L) Alexa Fluor 488 conjugated or goat F(ab)2 anti-mouse IgG (H+L) Alexa Fluor 594 conjugated (Thermo Fisher Scientific) secondary antibodies at 2 mg/ml for 30 min on ice, washed twice and acquired with a FACS Fortessa (BD Biosciences) flow cytometer. Analysis was performed with FlowJo software version 10.
Gene overexpression, gene KO and KD Human Nrp2 (Accession#AF022860), CD46 (Accession#NM_002389), TGFbRIII (Accession#XM_006710867) and THBD (Accession#AF495471) were ordered from GenEZ ORF database (Genscript) and cloned in pCDH-EF1-MCS (System Biosciences). Lentiviral particles were generated by PEI transfection of HEK293FT (Thermo Fisher Scientific) with pCDH-EF1-MCS (System Biosciences), pMD2.G (addgene) and psPAX (addgene) and purified on a sucrose cushion. ARPE-19 and MRC-9 cells at 70% confluency were transduced with lentiviral particles and expression was assessed after two days. HAP-1 KO by CRISPR/Cas9 of NRP2 and CD46 were generated by Horizon Genomics GmbH. HAP-1 KO by CRISPR/Cas9 of TGFbRIII was generated using three short guide RNAs (sgRNAs ordered from Genscript and individually cloned into the lentiviral vector plentiCRISPRv2 (addgene plasmid # 52961) (Sanjana et al., 2014) . Lentiviruses containing single guide RNAs were kept separated at all times and used to transduce HAP-1 cells. HAP-1 cells transduced with lentivirus were selected for 3 days with 0.5 mg/ml puromycin (Thermo Fisher Scientific). Single clones were expanded and effective KO of the target gene was analyzed by flow cytometry and confirmed by Sanger sequencing. Sequences of the guide RNAs used are listed thereafter. Western blotting ARPE-19, HUVEC and MRC-9 cells were grown to confluency in T75 culture flasks (Nunc, Thermo Scientific). Cells were washed twice with PBS and lysed with 1 ml/plate of ice-cold lysis buffer (1% n-Dodecyl-b-D-maltoside, 50 mM Tris pH 7.2, 150 mM NaCl, 1X complete protease inhibitor from Roche). Cell lysates were centrifuged for 30 min at 10000g and protein concentration was calculated using UV absorption. For western blot analysis 60 mg of each cell lysate were boiled in reducing SDS-PAGE loading buffer and subjected to SDS-PAGE NuPAGE 4%-12% Bis-Tris gradient protein gel (Thermo Scientific). Nrp2 was detected with a goat polyclonal anti-Nrp2 antibody (R&D system, AF2215), PDGFRa with anti-PDGFRa (clone C-9, Santa Cruz Biotechnology, Inc) and Tubulin with anti-a-Tubulin (clone B-7, Santa Cruz Biotechnology) in 1% nonfat dried milk/PBS for 4 hr at 4 C. UL-130Strep was detected with Strep,Tag II Monoclonal Antibody (Novagen, 71591-3).
Virus neutralization assay and microscopy analysis Confluent monolayers of ARPE-19, HAP-1, HUVEC or MRC-9 cells cultured in 96-well flat-bottom plates were infected at a multiplicity of infection (MOI) of 1. After 48 hr, cells were fixed with 5% acetic acid in methanol for 7 minutes on ice, washed four times with PBS and then stained with 0.5 mg/ml of mouse anti-pp72 antibody for 2 hr on ice. Cells were washed four times with PBS and incubated with 1 mg/ml of a goat F(ab)2 anti-mouse IgG (H+L) AlexaFluor 594-conjugated (Thermo Fisher Scientific). Cells were washed and counterstained with DAPI, and images were acquired on BD Pathway bioimaging system. The percentage of infected cells was automatically calculated by BD AttoVision software. The number of infected cells was plotted as histograms. Dose-response curves were generated by plotting the relative infected cells against the ligand or antibody dilutions. The protein concentration causing inhibition of 50% of infection (IC 50 ) was calculated by nonlinear regression, as previously described (Ciferri et al., 2015a (Ciferri et al., , 2015b Kabanova et al., 2016) .
Electron Microscopy and Image Processing
Images were acquired manually using a Tecnai Spirit transmission electron microscope (Thermo Fisher Scientific, Waltham, MA), operating at 120keV, at a nominal magnification corresponding to a pixel size of 2.7 Å , using a US1000 CCD (Gatan, Pleasanton, CA). 54 tilt pair (0 degrees, 60 degrees) images were acquired with a defocus of $-2 microns. All image pre-processing, two-dimensional classification, and RCT processing was done using the SCIPION image processing suite. 5542 particles were initially selected from the 0 tilt micrograph using XMIPP3 software and extracted using a 110 3 110 pixel box size. Initial reference-free classification using XMIPP3 yielded 25 classes, and from these five classes were selected for refinement. The best class was manually edited to remove images of aggregates, which resulted in a final RCT reconstruction containing 560 particle pairs. Visualization, fitting and final rendering of figures was performed using UCSF Chimera.
Chemical crosslinking coupled to mass spectrometry: Amine cross-linking A 100 mg aliquot of the protein complex was adjusted to a final concentration of approximately 1 mg/ml in 20 mM HEPES (pH 7.9), 200 mM NaCl. A 1:1 mixture of non-deuterated (d0) and deuterated (d12) disuccinimidyl suberate (DSS, Creative Molecules) was added to a final concentration of 1 mM from a 25 mM stock solution in dimethyl formamide. The cross-linking reaction was allowed to proceed for 30 min at 37 C before quenching by addition of ammonium bicarbonate to a final concentration of 50 mM. After a further incubation step (30 min, 37 C), the sample was dried in a vacuum centrifuge.
Carboxyl and zero-length cross-linking A 100 mg aliquot of the protein complex was adjusted to a final concentration of approximately 1 mg/ml in 20 mM HEPES (pH 7.1), 200 mM NaCl. A 1:1 mixture of non-deuterated (d0) and deuterated (d10) pimelic acid dihydrazide (PDH, Sigma-Aldrich) and the coupling reagent 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM) were added to final concentrations of 3.6 mg/ml PDH-d0/d10 and 4.8 mg/ml DMTMM, respectively. The cross-linking reaction was allowed to proceed for 30 min at 37 C before quenching by gel filtration (Zeba Spin Desalting Column, Thermo Scientific). The filtrate was dried in a vacuum centrifuge.
Sample processing and mass spectrometry analysis Dried samples were reconstituted in 8 M urea and treated with tris-(2-carboxyethyl)phosphine (2.5 mM, 30 min, 37 C) and iodoacetamide (5 mM, 30 min, 25 C, protected from light). The urea concentration was reduced to 5.5 M by addition of 150 mM ammonium bicarbonate, and endoproteinase Lys-C (mass spectrometry grade, Wako) was added at an enzyme-to-substrate ratio of 1:100. Following incubation for 3 h at 37 C, the samples were further diluted to 1 M urea by addition of 50 mM ammonium bicarbonate, and trypsin (sequencing grade, modified, Promega) was added at an enzyme-to-substrate ratio of 1:50. Samples were incubated overnight and digests were purified by solid-phase extraction using 50 mg tC18 cartridges (Waters). The resulting peptide mixtures were fractionated by size exclusion chromatography (SEC, Superdex Peptide 3.2/300, GE Healthcare Life Sciences), as described previously (Leitner et al., 2012) . Three high molecular weight fractions (elution volumes 1.0 -1.3 ml) were collected and were analyzed in duplicate on an Easy nLC 1000 HPLC system coupled to an Orbitrap Elite mass spectrometer equipped with a Nanoflex source (all ThermoFisher Scientific).
Identification of cross-linked peptides
Data analysis was performed using xQuest software. Mass Spect data were searched against a database containing the sequences of all complex members and three human keratins (K1C9, K2C1, K22E) that were identified as low-level contaminants (no cross-links on keratins were identified). Score cut-offs to achieve a false discovery rate of approximately 5% were determined as described (Leitner et al., 2014) . All spectra were manually evaluated and required to contain evidence for fragment ions representing at least four bond cleavages in total or three consecutive bond cleavages for both of the peptides. If the cross-linking site could not be unambiguously assigned on one of the two peptide chains, alternative site assignments are shown in Table S5 .
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, precision measures (mean ± SEM) and statistical significance are reported in the Figures and Figure Legends . Data were judged to be statistically significant when p < 0.05. No statistical methods were used to predetermine sample size, no blinding of investigators was required and no data points were excluded. Data were analyzed with Prism 7 (GraphPad Software) using the two-tailed non-parametric Mann-Whitney U test for two groups' comparison, or Kruskall-Wallis test (and Dunn's post-test) when three or more groups were compared (asterisks denote statistical significance *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001). Cell surface Interaction Screen data were analyzed and represented using Microsoft Excel (version 14.7).
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the mass spectrometry proteomics data reported in this paper are ProteomeXchange consortium via the PRIDE: PXD006269 and PXD007185. The accession number for the RCT reconstruction of the pentamer complex by Electron microscopy reported in this paper is EMDB: EMD-8884. All software used in this study are listed in the Key Resources Table. Supplemental Figures A) STM receptors as query proteins for proof-of-concept assays were screened against a test-set of 140 prey receptor ECD-Fc. CTLA4 and PVRL2 ECDs were expressed as pentamerized constructs using the same cloning strategy described for the HCMV trimer and pentamer. Query proteins were prepared and screened using the automated procedures described in the STAR Methods. The newly implemented platform allows detection of known receptor-receptor interactions characterized by binding affinities in the nM to mM range with high signal/noise ratios, as exemplified by CTLA4-CD80 or the PVRL2-CD226 interactions, respectively.
(legend continued on next page) (B) Expression of the receptor ECD-Fc library in the conditioned media. The concentration of each prey receptor ECD-Fc in the library was measured using TR-FRET, as described in the STAR Methods. Mean expression ± SEM for each receptor in the library is shown. Data represent five cell transfections performed with independent cell cultures. Around 90% of the receptor ECD-Fc clones express at concentrations higher than 1 mg/ml. (C) Detection of known receptor-receptor interacting pairs. The indicated recombinant proteins (Rec) or conditioned media supernatants (CM) were captured on protein A-coated plates at the indicated concentrations. Irrelevant recombinant proteins or conditioned media supernatants enriched for irrelevant receptor ECDFc are also shown as controls. (Left plot) Binding of HCMV trimer or (right plot) PDCD1 receptor produced as pentameric query proteins was tested following experimental procedures described in the STAR Methods. The high-affinity interaction between the trimer and PDGFRa proteins, and the micromolar interactions between PDCD1 and its counter-receptors were detected with high signal over background even when the prey proteins were captured at low densities. Altogether, these results indicate that using the workflow implemented in this study, the vast majority of the proteins in the receptor library are available for identification of PPI for query targets, expressed as oligomerized proteins.
(legend on next page) Figure S3 . Identification and Validation of Trimer and Pentamer Cell-Surface Interactors, Related to Figures 1 and 2 (A and B) Identification of putative cellular receptors for trimer and pentamer HCMV strain VR1814 strain. Colored circles represent receptors that interacted with trimer and pentamer, and their size corresponds to the relative score for each hit. PDGFRa, TGFbRIII and Nrg2 were identified as the strongest interactors for the VR1814 HCMV trimer, while Nrp2 and THBD were identified as the most prominent hits for the VR1814 HCMV pentamer. CD46, FCAR and LILRB3 receptors were identified as low scoring hits. Receptor library generation, HCMV trimer and pentamer baits tagging strategy and screening procedure and data analysis are detailed in the STAR Methods section. (C) Schematic representation of the gH-COMP-b-lactamase constructs: Glycoprotein H sequences from Merlin and VR1814 strains were cloned with the native signal peptide in a modified pRK vector and fused to a COMP pentamerization domain (PDB:1VDF) and the b-lactamase domain through a short linker. These constructs carried a 6His tag and a triple FLAG tag at the C-term to allow detection or purification. (D) Kinetic parameters shown in Figure 2 were calculated using BLI. HCMV complex interactors were captured on sensor chips and binding to soluble pentamer or trimer was measured. Data were fitted to a Langmuir model. Representative experimental fittings are shown. Figure S4 . Cell Surface Staining Showing Expression Level of Nrp2, CD46, THBD, and TGFbRIII in epithelial ARPE-19 Cells, MRC-9 fibroblasts, and HUVECs, Related to Figures 3 and 4 
